Toggle navigation
COVID-19
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
2022 AUA Annual Meeting
2022 Summit on Cancer Health Disparities
EHA2022 Congress
Digestive Disease Week 2022
2022 ASCO Annual Meeting
Calendar
View All
Topics
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
View All
Videos
Newsreels
Video Roundtables
Podcasts
Subscribe
Advertisement
Topics
Advertisement
Solid Tumors
Bladder Cancer
Breast Cancer
CNS Cancers
Colorectal Cancer
Gastroesophageal Cancer
Gastrointestinal Cancer
Gynecologic Cancers
Head and Neck Cancer
Hepatobiliary Cancer
Kidney Cancer
Lung Cancer
Pancreatic Cancer
Prostate Cancer
Sarcoma
Skin Cancer
Thyroid Cancer
Neuroendocrine Tumors
Hematologic Malignancies
Leukemia
Lymphoma
Lymphoma (Curated)
Multiple Myeloma
Myelodysplastic Syndromes
Issues in Oncology
Cost of Care
Geriatric Oncology
Global Cancer Care
Health-Care Policy
Legislation
Survivorship
Genomics/Genetics
Immunotherapy
COVID-19
Supportive Care
Integrative Oncology
Pain Management
Palliative Care
Symptom Management
Advertisement
Advertisement
Jul
05
Today In Oncology
Dual-Targeted Therapy Improves Outcomes vs Chemotherapy for Some Pediatric Patients With Low-Grade Glioma
EAU22 New Research Supports Risk-Based Prostate Cancer Screening
EAU22 Study Finds Gut Microbes Differ in Patients With Prostate Cancer vs Those With Benign Biopsy Results
New Consensus-Based Guidance on Managing Cancer Pain in Patients With Opioid Use Disorder or Opioid Misuse
Trastuzumab and Nivolumab Plus Either Ipilimumab or FOLFOX as First-Line Treatment for HER2-Positive Advanced Esophagogastric Adenocarcinoma
View More
Advertisement
